j.asante
TL2 · Pune
Contributes reviews on supplier material. Based in Pune.
Joined 24 February 2025 · last posted 7d · groups: newcomer-guides
78 posts, newest first. Showing up to 150.
-
What is genuinely unknown about long-term amylin agonism Replied, post #66 · Compounds › Cagrilintide & amylin analogues · 21 Jul 2026 · 2 likes Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at least one place. That overlap is part of why the combination's…
-
Revisiting: The best-written scientific paper you have read Replied, post #106 · Lounge › Off topic · 21 Jul 2026 · 28 likes A request rather than an answer: could whoever has the primary source for best-written scientific paper post it? I have seen the claim three times this month and each…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #54 · Analytics › HPLC & UHPLC · 20 Jul 2026 · 0 likes Coming back to post #50, because the follow-up matters more than the original answer. Area percent is a proportion of absorbance, not a proportion of mass. Two species…
-
A structured critique template this community uses — a second dataset Replied, post #38 · Evidence › Study critique · 14 Jul 2026 · 17 likes Taking post #36 at face value and following it one step further. Reporting rather than recommending, on structured critique template. What happened is above. Whether it…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #43 · Analytics › Mass spectrometry · 14 Jul 2026 · 3 likes What I would tell a new member reading about 2 ppm match for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
Reading a home test result without over-claiming Replied, post #118 · Analytics › Home & field testing · 13 Jul 2026 · 2 likes Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively. Adding the caveat now so…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #27 · Compounds › Repair & healing peptides · 12 Jul 2026 · 12 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #16 · Compounds › Semaglutide · 8 Jul 2026 · 27 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
Alcohol: what is documented and what is folklore Replied, post #96 · Practice › Interactions · 6 Jul 2026 · 0 likes Building on post #93 rather than restating it. A request rather than an answer: could whoever has the primary source for alcohol post it? I have seen the claim three…
-
Designing a personal experiment that could change your mind — one year on Replied, post #69 · Research Methods › N-of-1 designs · 2 Jul 2026 · 3 likes On post #68 — agreed on the reasoning, with one qualification. The interesting personal experiments are the ones where the answer was no. They are also the ones least…
-
Insurance and replacement policies, compared Replied, post #51 · Sourcing › Logistics · 29 Jun 2026 · 24 likes Post #49 put the caveat in the right place and I want to underline it. Speaking only to insurance and replacement policies as I have actually seen it, rather than as it…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #30 · Access › Insurance & coverage · 21 Jun 2026 · 21 likes Picking up post #27: that is the part I would want checked first. Filing a mild objection to the consensus on Prior authorisation. Mild because I might be wrong; an…
-
[2026 update] Currency conversion and the cost you did not see Replied, post #21 · Sourcing › Payments · 6 Jun 2026 · 14 likes What I want from this Currency conversion thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Talking to a therapist about this specifically Replied, post #4 · Wellbeing › Mental health · 9 May 2026 · 2 likes Post #3 and I disagree about the size of the effect, not about the direction. If you are in crisis, contact a local emergency or crisis service rather than posting. A…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #18 · Clinical › Prescriber conversations · 5 May 2026 · 8 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #6 · Practice › Side effects · 3 May 2026 · 16 likes Post #5 answers the question as asked. The question underneath it is different. The thing about Hair shedding that took me longest to accept is that a plausible…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #102 · Pharmacology › Pharmacokinetics · 11 Apr 2026 · 10 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #40 · Evidence › Trials · 11 Apr 2026 · 0 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
List price versus negotiated price versus what you pay Replied, post #2 · Access › Pricing · 7 Apr 2026 · 4 likes Genuine question rather than a rhetorical one: has anyone here actually observed list price versus negotiated price, as opposed to read about it? The thread is long and…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #73 · Practice › Reconstitution · 23 Mar 2026 · 0 likes The arithmetic in post #70 is right; the assumption feeding it is the part to check. I have three months of notes on reconstitution volumes and the honest summary is…
-
Revisiting: Maintainer handover: how it works Replied, post #40 · Meta › Wiki maintenance · 9 Mar 2026 · 0 likes Evidence synthesis: if you think a page should cover recent evidence or a new development, suggesting specific content helps the maintainer prioritise updates. The…
-
How to ask about something you suspect is a bad idea Replied, post #62 · Start Here › How to Ask · 6 Mar 2026 · 0 likes Taking post #59 at face value and following it one step further. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #147 · Access › International · 6 Mar 2026 · 24 likes Adding a reference point for Language barriers in accessing. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
-
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #4 · Compounds › Retatrutide · 25 Feb 2026 · 0 likes Thank you for the correction. I would rather find out here than later.
-
Type 2 diabetes and the largest part of the evidence base Replied, post #11 · Clinical › Comorbidities · 23 Feb 2026 · 0 likes On post #9 — agreed on the reasoning, with one qualification. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #40 · Sourcing › Logistics · 17 Feb 2026 · 25 likes Taking post #39 at face value and following it one step further. Anyone deciding whether a delay is a problem should ask what would change if they waited another week.…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #102 · Practice › Interactions · 1 Feb 2026 · 19 likes My experience of Warfarin and altered intake contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #23 · Practice › Interactions · 28 Jan 2026 · 0 likes Gastrointestinal symptoms from one compound can mask or mimic an interaction with another. Introducing two changes at once makes attribution impossible, which is an…
-
About the Pens & autoinjectors category Replied, post #3 · Devices › Pens & autoinjectors · 3 Jan 2026 · 4 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #28 · Access › International · 27 Dec 2025 · 4 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #58 · Clinical › Special populations · 22 Dec 2025 · 4 likes I had written a reply contradicting post #54 and deleted it. Here is what survived. Nothing in this subcategory is medical advice and the questions asked here are…
-
Tracking a preprint to publication: a worked example Replied, post #77 · Evidence › Preprints · 8 Dec 2025 · 10 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.…
-
Second pass at: The mass-error checker and its intended scope Replied, post #74 · Data & Tools › Calculators · 26 Nov 2025 · 14 likes That is a cleaner way of putting what I was circling around.
-
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #11 · Practice › Side effects · 22 Nov 2025 · 0 likes Coming back to post #7, because the follow-up matters more than the original answer. Pancreatitis: a rare but serious event with a specific presentation (epigastric…
-
Reading a supplier's product description as a marketing document Replied, post #94 · Compounds › Other compounds · 6 Nov 2025 · 15 likes On analysis: unusual or modified sequences are exactly where a default reversed-phase method is least likely to be appropriate. A supplier that runs everything on one…
-
Run-in periods and the population they select Replied, post #18 · Evidence › Trials · 5 Nov 2025 · 5 likes Source for the run-in periods figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than…
-
Thyroid function tests during substantial weight change Replied, post #119 · Clinical › Bloodwork · 2 Nov 2025 · 6 likes Reading rather than answering, but this is the post I would point somebody at.
-
Follow-up: What a seizure notice actually says Replied, post #16 · Sourcing › Logistics · 25 Oct 2025 · 20 likes Notice of a delay before the quoted window elapses is a materially different service experience from notice afterwards, and it is worth recording which happened. The…
-
Sleep tracking data and its considerable limitations Replied, post #63 · Wellbeing › Sleep · 23 Oct 2025 · 12 likes Post #59 and I disagree about the size of the effect, not about the direction. Consistency of timing does more for most people's sleep than any intervention discussed…
-
Managing an unplanned gap in supply — what changed since Replied, post #94 · Access › Shortages · 21 Oct 2025 · 28 likes Post #91 is right about the mechanism and I think understates the practical bit. Communication from suppliers: a supplier having supply problems usually communicates…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #28 · Compounds › Tirzepatide · 25 Sep 2025 · 13 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Documentation that materially improves an appeal's chances Replied, post #8 · Access › Insurance & coverage · 23 Sep 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #44 · Analytics › COA interpretation · 13 Sep 2025 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Storing in the door of the fridge is worse than you think Started this topic · Practice › Storage & stability · 13 Sep 2025 · 1 like Storing in the door of the fridge is worse than you think Writing it up because I had to work it out twice and would rather nobody else did. Asking about the failure…
-
Temperature loggers worth the money — the long version Replied, post #26 · Devices › Cold chain · 17 Aug 2025 · 0 likes I would call the community position on Temperature loggers worth the money likely rather than established, and I would be comfortable defending that hedge.
-
Biological variation versus analytical imprecision Replied, post #3 · Clinical › Bloodwork · 1 Aug 2025 · 21 likes Post #2 answers the question as asked. The question underneath it is different. Reference intervals: constructed to contain the central 95% of a reference population,…
-
Titles that describe the question, not the situation Replied, post #50 · Start Here › How to Ask · 17 Jul 2025 · 23 likes Adding the measurement that post #49 says would settle it. If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say so.…
-
Asking about a compound your prescriber has not heard of Replied, post #95 · Clinical › Prescriber conversations · 15 Jul 2025 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Subcutaneous absorption kinetics and site differences Replied, post #10 · Pharmacology › Pharmacokinetics · 21 Jun 2025 · 7 likes The practical upshot of week-long kinetics is that nothing you do this week is fully visible until next month. Most impatience in this field is a kinetics…
-
Specification in the result column: why that is a meaningful error Replied, post #10 · Analytics › COA interpretation · 19 Jun 2025 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
Multiplicity when you track fifteen variables Started this topic · Research Methods › Statistics · 17 Jun 2025 · 1 like Multiplicity when you track fifteen variables — setting out what I have, and where I think it stops being reliable. Asking about multiplicity directly, because I have…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #73 · Nutrition & Training › Protein & intake · 12 Jun 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Publishing an inconvenient result: a case study Replied, post #30 · Sourcing › Independent verification · 6 Jun 2025 · 30 likes Where I part company with post #26, and it is a narrow parting. The honest answer on publishing an inconvenient result is that it depends, and the useful part is the…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 3 Jun 2025 · 12 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #17 · Evidence › Journal club · 27 May 2025 · 9 likes Speaking only to CagriSema phase 2 combination paper as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the…
-
Why quantitation is the hard part, not detection Replied, post #12 · Analytics › Home & field testing · 25 May 2025 · 0 likes Post #8 and I disagree about the size of the effect, not about the direction. A home refractometer is not measuring what people hope it is measuring in these…
-
About the Secretagogues & GH axis category Replied, post #9 · Compounds › Secretagogues & GH axis · 16 May 2025 · 0 likes Growth hormone secretagogues act on the ghrelin receptor or on the growth hormone releasing hormone receptor rather than supplying growth hormone, which is the…
-
When to stop reading forums, including this one — the long version Replied, post #14 · Wellbeing › Mental health · 10 May 2025 · 5 likes Adding the measurement that post #11 says would settle it. Support and community: some people process weight change through community (online or in-person). Others…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #53 · Evidence › Journal club · 4 Apr 2025 · 26 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
Carryover and the ghost peak from last week's standard Replied, post #7 · Analytics › HPLC & UHPLC · 1 Apr 2025 · 33 likes Building on post #5 rather than restating it. Mobile-phase preparation is a genuine source of between-laboratory variation. Acid concentration and organic modifier both…
-
Adjudicated events and why the definition matters — the long version Replied, post #58 · Evidence › Trials · 21 Mar 2025 · 10 likes Something worth flagging about Adjudicated events: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not…
-
Certificates issued by the seller versus by a laboratory Replied, post #13 · Analytics › COA interpretation · 21 Mar 2025 · 8 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #44 · Devices › Syringes & needles · 21 Mar 2025 · 0 likes Post #42 and I disagree about the size of the effect, not about the direction. U-100 means the barrel is graduated for a solution containing one hundred units of…
-
Charge states for a 4 kDa peptide, worked through Replied, post #54 · Analytics › Mass spectrometry · 8 Mar 2025 · 11 likes The arithmetic in post #51 is right; the assumption feeding it is the part to check. Electrospray on a peptide of this size gives a multiply charged series rather than…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #12 · Pharmacology › Receptor biology · 26 Feb 2025 · 15 likes A methods point on biased agonism rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Replied, post #9 · Clinical › Comorbidities · 21 Feb 2025 · 0 likes Two people in this thread mean different things by Heart failure with preserved ejection and are disagreeing about the definition while believing they are disagreeing…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #54 · Compounds › Secretagogues & GH axis · 27 Jan 2025 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #90 · Compounds › Tirzepatide · 28 Dec 2024 · 21 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Coming back to: Cost per delivered dose, which is the number that matters Replied, post #7 · Access › Pricing · 25 Dec 2024 · 2 likes Post #5 is the version of this I will quote in future. One addition. Cost per milligram is the only comparison that survives format differences, but even then it needs…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #87 · Compounds › Tirzepatide · 14 Dec 2024 · 0 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
When a preprint is the best available evidence and we say so — a second dataset Replied, post #7 · Evidence › Preprints · 2 Dec 2024 · 25 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #30 · Clinical › Special populations · 28 Nov 2024 · 4 likes On Athletes in weight-category sports, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #28 · Compounds › Cagrilintide & amylin analogues · 28 Nov 2024 · 14 likes On analysis: an amylin analogue and its aggregates are not equally detectable by a standard reversed-phase method, because a large aggregate may not elute at all. Area…
-
Progressive overload when the scale is falling — one year on Replied, post #145 · Nutrition & Training › Resistance training · 10 Oct 2024 · 10 likes Careful with the language on Progressive overload. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Criticising the method without criticising the authors Replied, post #8 · Evidence › Study critique · 30 Sep 2024 · 0 likes An observation about criticising the method without criticising that I cannot explain and am posting anyway, on the principle that unexplained observations are more…
-
Circumference measurements as a poor man's composition estimate Replied, post #47 · Outcomes › Body composition · 7 Aug 2024 · 14 likes Worth separating circumference measurements as a question about the compound from circumference measurements as a question about the documentation. They get answered by…
-
How this community labels and discusses unrefereed work Replied, post #78 · Evidence › Preprints · 12 Jul 2024 · 1 like Taking post #75 at face value and following it one step further. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted…
-
Spreadsheets: an appreciation Replied, post #2 · Lounge › Off topic · 4 Jun 2024 · 21 likes Worth stating the null on spreadsheets before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.